Thymopentin

Also known as: TP-5, Timunox

ImmunePHASE 2

Clinical Status

Approved in some countries — clinical trials for autoimmune conditions.

Mechanism of Action

The active pentapeptide fragment (positions 32-36) of thymopoietin. Retains full biological activity in promoting T-cell differentiation, enhancing IL-2 production, and modulating immune responses with fewer side effects than the full protein.

Dosing Defaults

Dose

1 mg

Frequency

3x weekly

Administration

Subcutaneous injection

Timing

Morning

Food

with or without

Duration

4-12 weeks

Dose range: 0.5-2 mg per dose

Morning dosing aligns with circadian immune function peaks.

Side Effects

•Injection site reactions
•Mild nausea
•Transient fever
•Headache

Contraindications & Warnings

⚠Organ transplant recipients

•Not medical advice

Compare

Compare Thymopentin with another peptide side-by-side.

Calculate Dose

Use the reconstitution calculator to prepare your Thymopentin dose.

Open Calculator

Related Immune Peptides

LL-37

PHASE 1

Immune

Antimicrobial peptide with broad-spectrum activity and wound healing properties.

KPV

PRECLINICAL

Immune

Anti-inflammatory peptide fragment. Does NOT cause immunosuppression.

Thymosin Alpha-1

PHASE 3

Immune

Thymic peptide for immune modulation. Approved in 35+ countries.

VIP

PHASE 2

Immune

Immunomodulatory peptide used in mold illness (CIRS) protocols.

This information is for educational purposes only and is not medical advice. Dosing data is based on research literature and community reports. Always consult a qualified healthcare provider before using any peptide.